ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,676Medicare Part D Prescriptions Filled, Including Refills

Rank: 194 out of 1006

$457K Total Retail Price of All Prescriptions

Rank: 267 out of 1006

442 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 7,314 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 416 390 1 2
LISINOPRIL 397 381 2 3
LOVASTATIN 282 248 3 44
AMLODIPINE BESYLATE 254 254 4 4
METOPROLOL TARTRATE 249 245 5 7
WARFARIN SODIUM 238 238 6 8
SIMVASTATIN 219 213 7 1
ATORVASTATIN CALCIUM 192 188 8 5
OMEPRAZOLE 173 145 9 9
FUROSEMIDE 165 161 10 6
ALENDRONATE SODIUM 139 131 11 29
METFORMIN HCL 135 118 12 10
METOPROLOL SUCCINATE 132 122 13 12
HYDROCHLOROTHIAZIDE 128 127 14 11
ZOLPIDEM TARTRATE 119 113 15 14
ATENOLOL 110 100 16 13
JANUVIA 107 97 17 49
PRAVASTATIN SODIUM 101 101 18 15
DONEPEZIL HCL 100 100 19 17
SERTRALINE HCL 94 94 20 19
LOSARTAN POTASSIUM 85 69 21 22
DIOVAN 79 75 22 16
HYDROCODONE-ACETAMINOPHEN 74 72 S3 23 25
OXYBUTYNIN CHLORIDE ER 73 66 24 92
NEXIUM 69 68 25 28
ZETIA 68 54 26 51
CRESTOR 68 65 26 18
LIDODERM 66 65 28 66
PAROXETINE HCL 62 62 29 62
CITALOPRAM HBR 61 60 30 24
GABAPENTIN 60 60 31 20
TRAZODONE HCL 60 60 31 21
TRAMADOL HCL 57 57 33 35
GLYBURIDE 56 56 R 34 65
VESICARE 55 55 35 163
LANTUS 55 55 35 43
SYNTHROID 54 40 37 42
VERAPAMIL ER 53 53 38 116
POTASSIUM CHLORIDE 52 52 39 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.